Overview of Mirabegron 25 mg + Silodosin 8 mg Tablets
We offers a premium combination formulation of Mirabegron 25 mg and Silodosin 8 mg tablets, carefully developed to provide a dual-action approach for men suffering from overlapping urinary tract conditions. This novel medicine enhances clinical results & treatment compliance by combining the advantages of two well-established active pharmaceutical ingredients in a single, easy-to-take oral dose. For individuals with complicated urological characteristics, this formulation provides a complete answer by treating both storage & voiding problems.
As a Mirabegron 25 mg tablets manufacturer and Silodosin 8 mg tablets manufacturer, Janus utilizes state-of-the-art manufacturing facilities, advanced equipment, and strict quality control processes to ensure consistency and reliability in every batch. Each tablet is produced using scientifically validated formulations that guarantee accurate dosage, long-term stability, & therapeutic effectiveness.
Mirabegron acts as a β₃-adrenergic receptor agonist, relaxing the detrusor muscle in the bladder and increasing its storage capacity. This lessens symptoms like frequency & urgency. On the other hand, Silodosin functions as a selective α₁-adrenergic receptor antagonist, which relaxes the smooth muscles in the prostate and bladder neck, thereby improving urinary flow and reducing obstruction. Together, these mechanisms provide synergistic relief for conditions like Overactive Bladder (OAB) & Benign Prostatic Hyperplasia (BPH).
As a trusted Mirabegron and Silodosin tablets supplier, Janus is committed to delivering high-quality pharmaceutical products to healthcare providers, hospitals, and distributors across domestic and international markets. With Janus, partners gain access to a dependable supply chain & a team dedicated to advancing urological health through innovation & excellence.
Therapeutic Uses
The combination leverages the strengths of both medications to target two major urinary conditions:
• Overactive Bladder (OAB): Mirabegron, a selective β₃-adrenergic receptor agonist, relaxes the detrusor smooth muscle during bladder filling. This increases bladder capacity, reduces urinary urgency and frequency, and lowers the incidence of incontinence.
• Benign Prostatic Hyperplasia (BPH): Silodosin, a highly selective α₁-adrenergic receptor antagonist, relaxes smooth muscle in the prostate, bladder neck, and prostatic urethra, improving urinary flow and alleviating lower urinary tract symptoms.
Together, the Mirabegron and silodosin tablets supplier combination addresses both OAB and BPH symptoms simultaneously, offering a comprehensive solution for men experiencing overlap of these conditions. The combination has shown effectiveness in enhancing urinary flow, reducing urgency, frequency, and improving quality of life.
Regulatory & Quality Standards (Certifications)
At Janus, manufacturing of our Mirabegron 25 mg tablets and Silodosin 8 mg tablets adheres strictly to current Good Manufacturing Practices (cGMP). Our facilities are compliant with WHO GMP guidelines, ensuring robust quality systems & safety standards. Certificates include:
• WHO-GMP compliance
• ISO 9001:2015 Quality Management System certification
• Local regulatory approvals as per Indian pharmaceutical manufacturing norms
Our certification lineup reinforces our position as a dependable Mirabegron 25 mg tablets manufacturer and Silodosin 8 mg tablets manufacturer, trusted by healthcare professionals for consistency and excellence.
Available Services
Janus offers a suite of services to support business partners:
• Custom Manufacturing – Flexible production capacities to meet both small-scale and high-volume demands.
• Private Labeling – Tailor packaging and branding for distributor-specific requirements.
• Regulatory Support – Assistance with registration, dossier preparation, and compliance documentation.
• Quality Assurance & Control – Full traceability, stability testing, impurity profiling, and Certificates of Analysis (CoA)/Certificate of Pharmaceutical Product (CPP).
• Reliable Supply Chain – On-time deliveries nationwide, with efficient logistics and packaging systems.
• After-Sales Support – Technical support, pharmacovigilance reporting, and risk communication as needed.
• Regulatory Export Services – Documentation and testing support for export markets.
These offerings position Janus as a trusted Mirabegron & silodosin tablets supplier, able to support both domestic & global pharmaceutical distribution networks.
Why Choose Us
Janus Biotech is a trusted Mirabegron 25mg tablets manufacturer & Mirabegron and Silodosin tablets supplier, offering a clinically proven dual-action formulation for effective management of Overactive Bladder (OAB) & Benign Prostatic Hyperplasia (BPH). Produced in WHO-GMP and ISO-certified facilities, our Mirabegron 25mg + Silodosin 8mg tablets meet the highest standards of quality, safety, and therapeutic performance. Backed by a skilled team & a robust supply chain, we deliver not only superior products but also long-term partnerships built on trust & excellence.
FAQ’s
1. What are Mirabegron 25 mg + Silodosin 8 mg tablets used for?
They are prescribed for treating overactive bladder (OAB) symptoms—such as urgency, frequency, and urge incontinence—as well as urinary flow problems caused by benign prostatic hyperplasia (BPH) in men.
2. How does this combination work?
Mirabegron relaxes bladder muscles to improve storage capacity, while Silodosin relaxes the muscles in the prostate and bladder neck, making it easier to pass urine.
3. Who can take these tablets?
They are generally recommended for adult men with OAB and/or BPH symptoms. A doctor’s evaluation is necessary before starting treatment.
4. Are there any common side effects?
Some patients may experience dizziness, headache, constipation, dry mouth, or nasal congestion.
5. How should the tablets be taken?
Swallow the tablets whole with water, usually once daily at the same time each day, or as directed by your healthcare provider.
